A Primer on Drug Addiction, Crime, and Treatment
Part 4 of 4 in the Series on Disproportionate Incarceration of Minorities for Drug Crimes
Illinois Criminal Justice Information Authority
This research was supported by Grant # 02-DB-BX-0017 awarded by the Bureau of Justice Assistance, Office of Justice Programs, U.S. Department of Justice, through the Illinois Criminal Justice Information Authority. Points of view or opinions contained within this document are those of the author and do not necessarily represent the official position or policies of the U.S. Department of Justice or the Illinois Criminal Justice Information Authority.
This report is the fourth in a series of publications on the disproportionate number of
African Americans who have been incarcerated for drug crimes in Illinois. The first report in
the series examined racial disproportionality in sentences for drug crimes from a national
perspective (Lurigio, 2003), the second described the passage of drug laws in Illinois from
1985 to 2002 (Lurigio, Heaps, and Whitney, 2002), and the third focused on racial disparities
in sentences for drug crimes in Illinois (Lurigio, 2006). TASC and Loyola University
Chicago collaborated on these publications as part of the Disproportionate Minority
Confinement Workgroup, funded by the Illinois Criminal Justice Information Authority
(ICJIA) and created in response to a 2000 Human Rights Watch (HRW) report that found
Illinois led the country in the disproportionate incarceration of African American men for
drug crimes, especially compared to White men convicted for the same classes of drug
offenses (HRW, 2000). The work group convened to inform the public about drug-related
sentencing disparities in Illinois and to encourage a dialogue among criminal justice
professionals and politicians who could help remedy the problem.
Previous reports in this series indicated that the passage of onerous drug laws in
Illinois led to increasingly large numbers of drug-related arrests, prosecutions, convictions,
and incarcerations, mostly for Class-4 felony possession charges (Lurigio, 2003; 2006). For
example, from 1994 to 2003, drug arrests increased 26 percent in Cook County, 22 percent in
Chicago, and 49 percent in suburban Cook County. During the same period, the number of
drug arrests in Illinois, outside Cook County, more than doubled from 264 to 561 per
100,000 residents (ICJIA, 2004). The number of people incarcerated for drug crimes in
Illinois and across the country exploded from the 1980s to the early 2000s (Lurigio, 2003,
2006), heightening the problem of racial disparities in sentencing and calling attention to the
The present report consists of four sections, focusing on drug addiction, crime, drug
treatment, and system reform. The first section describes drug abuse and dependence and
discusses the types and effects of drugs, the addictive process, and the nature and extent of
substance use disorders. The second section explains the basic categories of drug offenses,
the federal schedule of illegal drugs, the relationship between drug use and crime, and the
prevalence of drug use and substance use disorders in the general and correctional
populations. The third section briefly discusses the types of treatments for addiction,
summarizes evidence for the effectiveness of drug treatment, and reviews the principles of
science-validated drug treatment, including the usefulness of coerced drug treatment for
people under the control of the criminal justice system. The fourth and final section presents
a comprehensive framework of drug-related justice reforms as an alternative to the prevailing
Drug abuse and dependence disorders are chronic but treatable brain diseases,
involving compulsive drug-seeking and -using behaviors that persist despite immediate or
potentially harmful consequences for users and their families and communities. Drug abuse
and dependence are serious threats to public health and safety, costing hundreds of billions of
dollars in yearly healthcare expenditures, crime, poor work productivity, and job loss
(Hoffman & Fromeke, 2007). For example, illegal drug use in the United States cost nearly
200 billion dollars in 2002; approximately two-thirds of the costs (129 billion) were
economic losses attributable to people’s inability to work because of drug-precipitated
illness, premature death, or incarceration. The treatment of healthcare problems of drug
addicts cost 16 billion dollars, while drug-related criminal justice and welfare costs totaled 36
billion dollars in 2002 (Office of National Drug Control Policy, 2004). Addiction can also
result in intangible costs, such as homelessness, academic failure, and troubled relationships,
and is one of the most pervasive and intransigent mental health disorders in the world,
affecting the thoughts, feelings, and behaviors of millions of people annually (World Health
Drugs are psychoactive substances that change moods and behaviors by altering brain
chemistry and function (Hyman & Malenka, 2001). Drugs of abuse include medically
prescribed (e.g., barbiturates and pain relievers), legal (e.g., alcohol and nicotine), and illegal
(e.g., marijuana and heroin) substances. Some drugs, such as alcohol, have been used since
ancient times, whereas others, such as methamphetamines and designer drugs (e.g., Ecstasy),
are relatively new. People consume drugs to feel good (some drugs produce euphoria,
confidence, and relaxation), to keep from feeling bad (some drugs combat anxiety,
depression, and hopelessness), to accelerate performance (some drugs sharpen attention and
enhance physical strength and athletic prowess), and to experience altered sensory
perceptions (some drugs cause visual, auditory, or tactile hallucinations) (National Institute
Drugs of abuse can be classified into five groups according to effects. The first class
consists of stimulants, which increase alertness and decrease fatigue; examples include
amphetamines, Benzedrine, caffeine, Dexedrine, ephedrine, and nicotine. The second class
consists of depressants, which reduce tension, alleviate nervousness, and induce sedation.
Among these drugs are Nembutal, Seconal, Tunial, Veronal, Valium, and Xanax. The third
class, hallucinogens, changes sensory perceptions; examples include cannabis, Lysergic Acid
Diethylamide (LSD), Mescaline, Phencyclidine (PCP), and psilocybin. The fourth class
consists of opiates, which induce sleep, euphoria, and relaxation as well as relieve pain and
anxiety; opiates include codeine, heroin, opium, OxyContin, Percodan, and morphine. The
fifth class consists of performance enhancers; they increase athletic strength and speed and
stimulate the growth and recovery of skeletal muscles. Anadrol, Depo-Testosterone,
Dianabol, and Winstrol are some examples of such performance enhancers (Abadinsky,
Drug abusers typically prefer one class of drugs over others. However, when they
have difficulty obtaining their drug of choice, they often turn to other drugs in the same class
that produce similar effects. Psychoactive drugs in the same class can be compared on the
basis of their potency and efficacy. The potency of a drug is the amount that must be ingested
to produce a desired effect whereas efficacy is a drug’s ability to produce a desired effect
regardless of dosage. Both the strength and the potency of a substance can determine an
abuser’s drug of choice as well as the drug’s potential for abuse and dependence (see below)
Drug use can escalate to substance use disorders: abuse or dependence. The
progression to uncontrolled use depends on several risk factors. For example, biological
factors play a role in addiction; in other words, genetics can predispose a person to addictive
behavior—a predisposition that is shared among close biological relatives. Scientists estimate
that genes account for nearly half of a person’s vulnerability to a substance use disorder
Age of first use and psychiatric history are also important factors for explaining drug
use problems. Younger users are more likely to become addicted because developing
adolescent brains are more susceptible to a drug’s ability to change brain chemistry and
functions. Likewise, people with mental illness are also more likely to abuse or become
dependent on drugs. In addition, a person’s exposure to a parent’s or a peer’s use of drugs
can increase his or her risk of addiction. The mode of drug ingestion can also raise the
potential for abuse and dependence: a drug that is inhaled or injected is more addictive than
one that is ingested orally. Inhalation and injection send the drug to the brain faster and
produce more intense highs and lows. Drug-seeking behavior intensifies in response to the
cycle of peaks and valleys that the user experiences (Hoffman & Fromeke, 2007).
Psychoactive drugs are thought to become addictive through their activation of the
brain’s mesocorticolimbic dopamine pathway, extending from the brain’s ventral tegmental
area to the nucleus accumbens to the frontal cortex. Drugs of abuse stimulate this pleasure
circuit by increasing the amount of dopamine in the brain two- to ten-fold, creating an
extremely pleasurable experience for users that compels them to repeat the incident. Drugs of
abuse either mimic the effects of dopamine on neurotransmitters (i.e., they act as agonists) or
block the reabsorption of dopamine so that it can continue to activate neurons (i.e., they act
as antagonists). Eventually, the brain shuts down its own production of dopamine, causing
the user to ingest the drug merely to stave off feelings of listlessness, depression, and other
withdrawal symptoms. Drugs of abuse also affect the brain’s frontal regions, impairing
judgment and leading addicts to crave drugs even as the rewards of use steadily diminish.
Hence, relapses—a return to drug use after a period of abstinence—are common among
people with substance use disorders and can be triggered by stress, mood changes, and cues
that remind the abuser of the substance (Karch, 2007; NIDA, 2007).
Substance abuse and dependence disorders are diagnosed according to criteria in the
American Psychiatric Association’s Diagnostic and Statistical Manual IV-TR (American
Psychiatric Association, 2007). A substance abuse disorder is diagnosed when drug use in the
previous 12 months has led to significant distress and impairment in functioning and meets at
least one of several diagnostic criteria—namely, failure to fulfill obligations at work, school,
or home; recurring use of substances in dangerous situations (e.g., driving while intoxicated);
recurring substance use-related criminal justice involvement; and continued substance use
A drug-dependence disorder—more serious than a drug-abuse disorder—is diagnosed
when drug use in the previous 12 months has reached the level of abuse and meets at least
three of seven criteria that include tolerance (i.e., increasing amounts of the drug must be
taken to achieve desired effects), physical withdrawal (i.e., symptoms that accompany the
cessation of drug use, such as tremors, chills, drug craving, restlessness, bone and muscle
pain, sweating, and vomiting), and persistent failure to reduce drug consumption.
Prevalence of Drug Use and Substance Use Disorders General population. The National Survey on Drug Use and Health assesses the
prevalence of substance use and substance use disorders in the United States. In 2005, an
estimated 20 million Americans age 12 or older (or 8 percent of the total population in this
age group) reported having used an illicit substance in the previous month; marijuana was the
most commonly used drug (15 million), followed by cocaine (2 million), hallucinogens (1
million), methamphetamine (580,000), and heroin (166,000). Meanwhile, an estimated 22
million people age 12 or older were classified with a substance abuse or dependence problem
(9 percent of the population). Among them, more than 3 million were classified with abuse of
or dependence on both alcohol and illicit drugs; more than 3.5 million had abused or were
dependent on illicit drugs but not alcohol; and more than 15 million had abused or were
dependent on alcohol but not illicit drugs (Substance Abuse and Mental Health Services
In 2005, within the general population, the relative percentages of people who
reported the use of different illicit drugs in their lifetime paralleled the percentages of people
who reported the use of different illicit drugs during the past month. In other words, for both
lifetime and past month use, marijuana was the most frequent illicit drug used, followed by
crack or powder cocaine, hallucinogens, methamphetamine and heroin. For example, nearly
half (46 percent) of people age 12 and older reported the lifetime use of any illicit substance,
with marijuana as the most popular drug (40 percent), followed by powder or crack cocaine
(17 percent), hallucinogens (14 percent), methamphetamine (4 percent)
Correctional population. The prevalence of drug use and substance use disorders is
significantly higher in the criminal justice and correctional population than in the general
population. In 2003, the Arrestee Drug Abuse Monitoring (ADAM) Program found that
nearly two-thirds (median among 39 sites) of male arrestees tested positive for one or more
of five illicit drugs at the time of arrest (marijuana, opiates, cocaine, methamphetamine,
PCP). For example, in Chicago, 86 percent of male arrestees tested positive for one or more
of these drugs—53 percent tested positive for marijuana; 51 percent, for powder cocaine; 25
percent, for opiates; and 1 percent, for methamphetamine. Approximately half were assessed
as heavy drug users (52 percent) or at risk of substance dependence (49 percent) (Zhang,
In 2004, 83 percent of state prisoners reported lifetime use of any illicit substance —
78 percent, marijuana use; 47 percent, cocaine or crack cocaine use; 33 percent, hallucinogen
use; 29 percent, amphetamine or other stimulant use; 23 percent, heroin or other opiate use;
and 21 percent, barbiturate or other depressant use (Mumola & Karberg, 2006). The
percentages of drug use among jail detainees in 2002 indicate similar rates; specifically, 82
percent reported lifetime use of any drug, 76 percent, marijuana use, and 48 percent, cocaine
or crack cocaine use. More than two-thirds of jail detainees were diagnosed with a substance
use disorder; these diagnoses were highest among detainees convicted of burglary (Karberg
In 2004, much larger percentages of state prisoners also reported past-month drug use
than members of the general population. More than half of inmates (56 percent) indicated
that they used drugs in the month before their current offense. The most commonly used drug
was marijuana (40 percent), followed by cocaine (21 percent), methamphetamine (11
percent), heroin (8 percent), and hallucinogens (6 percent).
Several national surveys of adult prison inmates, jail detainees, and probationers have
all shown that many were under the influence of drugs when they committed the offenses for
which they had been most recently arrested. For example, more than half of state and federal
prisoners in the late 1990s indicated they had been under the influence of alcohol or drugs
when committing their offenses (Munola, 1999; Mumola & Bonczar, 1998). In 2004, a
combined total of 58 percent of state (32 percent) and federal (26 percent) prison inmates
reported being under the influence of drugs when they committed the crime for which they
had been most recently arrested. Being under the influence of drugs during the commission
of a recent crime was most common among state inmates convicted of drug and property
crimes and among federal inmates convicted of drug and violent crimes (Mumola & Karberg,
Jail detainees with mental health problems were more likely than those with no
mental health problems to report drug use in the month before their recent arrests—60
percent versus 40 percent, respectively (Mumola & Karberg, 2006). Similarly, a study of
prison inmates showed that substance use disorders were more common among those with
mental health disorders than those with no mental health disorders—74 percent versus 56
percent, respectively (Mumola & Karberg, 2006). The use of illegal drugs was also found to
be more common among prison inmates who reported a history of physical, emotional, or
Schedule of Controlled Substances
Crime and illicit drug use, especially the use of narcotics (opiates, opiate derivatives,
and cocaine), have been closely linked since the passage of the Harrison Act in 1914, which
made the distribution of narcotics a federal felony offense. Prior to this act, narcotics were
the basic ingredients in numerous nonprescription or patent medicines that claimed to cure a
variety of symptoms and illnesses. The typical narcotics user then was a white, middle-aged
woman (Musto, 1987). The Harrison Act profoundly influenced public perceptions about
illicit drug use. Mostly because of the political climate surrounding this and other anti-drug
legislation, illicit drug use in the United States has been (and still is) viewed predominantly
as a criminal justice instead of a public health problem (Massing, 1998). Since the
introduction of drug-law enforcement strategies, policing activities have focused on young
male narcotics users from minority groups (Musto, 1987).
In 1970, Congress passed the Controlled Substances Act as Title II of the
Comprehensive Drug Abuse Prevention and Control Act. The purpose of the law was to
place the manufacture, importation, distribution, and possession of certain psychoactive and
other substances under federal authority and regulation. The legislation created five
schedules (I-V) that categorize drugs according to their medical use and potential for abuse
and are arranged in descending order of potential for abuse and ascending order of approved
medical use in the United States. Schedule I drugs, such as heroin and Ecstasy, have no
accepted medical use and a high potential for abuse while schedule V drugs have an accepted
medical use (i.e., they are available only for medical purposes) and a low potential for abuse
(e.g., Lomotil and Motofen, the brand names of medications used to treat diarrhea).
Illegal drugs are involved in drug-defined, drug-related, and drug-induced crimes.
Drug-defined offenses are violations of laws that prohibit the manufacture, distribution,
possession, or sale of illegal substances (e.g., amphetamines, cocaine, heroin, or marijuana).
Drug-related offenses result from an individual’s need for money to purchase drugs (e.g.,
property crimes and prostitution) or are occasioned by conflicts inherent in the illicit drug
trade (e.g., violence among competing drug dealers). The psychoactive effects of illicit
substances (and alcohol) can encourage reckless or violent behaviors or result in drug- or
alcohol-induced offenses, such as driving under the influence and domestic battery. These
crimes are drug-induced offenses (see below).
Overview. The association between drug use and crime is complex (White & Gorman,
2000). Studies have found no single, specific, or direct cause-effect relationship between
drug use and criminal activity, which is neither an inevitable consequence of illicit drug use
(apart from the illegal nature of drug use itself) nor a necessary or sufficient condition for
criminal behavior. Many illegal drug users commit no other types of crimes (Nurco, 1998).
An unknown number of illegal drug users—perhaps even dependent users—are able to
maintain steady employment and stable relationships. Because drug use is an illegal and
socially undesirable behavior, accurate, self-reported estimates of the size and nature of this
hidden population are difficult to obtain from national prevalence surveys (Waldorf,
People can commit crimes while using illegal drugs without there being a causal
connection between the two activities. Most crimes result from a variety of personal,
situational, cultural, and economic factors; hence, even when drug use is a cause, it is more
likely to be only one factor among many (White & Gorman, 2000). Therefore, no evidence
suggests drug use alone leads inevitably to criminal activity. The same conclusion applies to
the association between alcohol use and crime, which is also influenced by multiple factors
(Lurigio & Swartz, 1999; Office of National Drug Control Policy, 1997). As White and
Gorman (2000) aptly noted, “Just as there are many types of criminals and noncriminals
among drug users, there are also many types of drug users and nonusers among criminals” (p.
187). Notwithstanding the complexity of the drug-crime connection, several models have
been proposed to explain the relationship between drug use and crime: the
psychopharmacological model, the reciprocal or common-cause model, the economic-
motivation model, and the systemic model (White & Gorman, 2000).
Psychopharmacological model. The psychopharmacological model posits that the
direct effects of psychoactive drugs (e.g., disinhibition, cognitive deficits and distortions,
paranoia) lead to criminal behavior, especially violence (Fagan, 1990; Goldstein, 1985). In
this explanatory model, the side effects of chronic drug use, such as sleep deprivation,
neuropsychological impairment, and withdrawal symptoms (e.g., irritability), can also
increase the propensity toward violent or other illegal acts (Virkkunend & Linnslie, 1993). A
survey of violent crime victims indicated that nearly 30 percent believed the offender was
using drugs and/or alcohol at the time of the victimization (Bureau of Justice Statistics,
2007). Although little research has established a conclusive casual connection between
violence and illicit drug use, including cocaine, heroin, and marijuana, numerous studies
have linked alcohol use to violent behavior (White & Gorman, 2000).
Reciprocal or common-cause model. Contrary to common beliefs about the direction
of the relationship between drug use and crime, the reciprocal or common-cause model posits
that criminal involvement causes drug use by providing situations or environments that are
conducive to drug use and sales (Collins, Hubbard, & Rachal, 1985). In this perspective,
criminals use drugs either immediately before committing offenses to lower their anxiety or
immediately after committing offenses to celebrate their success (Hamid, 1998; Wright &
Decker, 1996). In general, the theory that crime precedes drug use suggests that drug use is
simply another form of deviant behavior, with criminal involvement affording many
Delinquent and criminal behaviors can predate drug use among juveniles (Johnson,
O’Malley, & Eveland, 1978). For example, the National Youth Survey showed that minor
delinquency led to alcohol consumption and more serious offenses, which led to marijuana
and polydrug use (in that order). Minor delinquency preceded drug use in nearly all cases
studied (Huizinga, Menard, & Elliott, 1989).
The relationship between drug use and crime can be bidirectional and mutually
reinforcing; specifically, as people commit more income-generating crimes, they find it
easier to buy drugs as “a consumer expenditure” (White & Gorman, 2000, p. 175).
Consequently, as people use drugs more frequently, they are compelled to commit more
crimes to support their growing addiction. According to this theory, drug use and crime are
interrelated; the correlation between drug use and criminality lies at the intersection between
addiction and criminal pursuits (Hamid, 1998).
For many youth, drug use and delinquency are not causally related in either direction.
Instead, they are contemporaneous; both behaviors arise from common causes, such as social
disaffection, poor relationships with parents, school failure, and deviant peers (Hamid, 1998;
Inciardi, Horowitz, & Pottieger, 1993). Among adult offenders, the connection between drug
use and crime can be explained by criminal subculture theory (Fagan, Weis, & Cheng, 1990;
McLellan, Luborsky, Woody, O’Brien, & Kron, 1981). In this framework, members of
criminal subcultures are described as self-indulgent, hedonistic, materialistic, and risk
seeking (i.e., they are committed to living the "fast life") (White, 1990; Wright & Decker,
1996). For these individuals, drug use and crime operate along parallel lines and are
components of a larger constellation of destructive behaviors that also include high-risk
sexual practices (Inciardi, et al., 1993). Hence, illicit drug use and criminal activity often
occur simultaneously and are mutually reinforcing aspects of a deviant lifestyle (e.g., Ball,
Shaffer, & Nurco, 1983; Collins & Messerschmidt, 1993).
Economic motivation model. The economic motivation model posits that drug users
commit crimes to obtain money to purchase illegal substances (Goldstein, 1985). Three types
of studies support an income-generating explanation for the drug-crime nexus: studies of the
relationship between illegal income and drug purchases, studies of the relationship between
drug use intensity and criminal activity, and studies of the effects of drug treatment on drug
use and criminal activity (Lurigio & Swartz, 1999; White & Gorman, 2000). At the most
intense levels of drug use, drugs and crime are directly and highly correlated (Lurigio &
Although substance use itself is not necessarily the cause of criminal behavior, as
discussed earlier, the need for money to purchase drugs can certainly be a motivating factor
for criminally active drug users (Lurigio & Swartz, 1999). Illegal drug use intensifies
criminal activity among crime-prone individuals. As illegal drug use increases in frequency
and amount, so does criminal behavior (Anglin & Speckart, 1988); conversely, as offenders’
drug use decreases, so does the number of crimes they commit. Thus, serious drug use can
amplify and perpetuate pre-existing criminal activity (Wright & Decker, 1996). For example,
a study of heroin-dependent people found that their criminal activities decreased by more
than 80 percent during the months and years in which they refrained from the use of the drug
and other opiates (Ball, Rosen, Flueck, & Nurco, 1981).
The annual National Youth Survey found that juveniles who commit serious crimes
are significantly more likely to use drugs than juveniles who commit minor crimes or no
crimes at all (Johnson, Wish, Schmeidler, & Huizinga, 1993). Other long-term studies of
youth have also found that delinquents who commit more serious offenses are heavier drug
users than those who commit less serious offenses (Elliot, Huizinga, & Ageton, 1985).
Consistent with research on the relationship between drugs and crime among youth, a survey
of adult drug users revealed that they had engaged in numerous criminal activities—
excluding drug-law violations—in the 90 days before they were interviewed for the study
(Inciardi, McBride, McCoy, & Chitwood, 1995).
Investigators have shown that offenders' income from property crime increases
proportionately with their drug use (Ball, et al., 1981). In one study, heroin users reported
that 90 cents of every illegal dollar they earned was spent on drug purchases (Goldman,
1981). Other researchers have found a direct relationship between illegal income and drug
spending among cocaine users (Spunt, Goldstein, Bellucci, & Miller, 1990). The need to
generate an income to purchase illegal drugs often leads to prostitution among drug-addicted
women; estimates suggest that between 40 and 70 percent of female narcotic addicts
maintain their drug habits by earning money through the sex trade (Erickson & Watson,
1990; McBride & McCoy, 1993). The exchange of sex for drugs seems to be especially
common among women who use crack cocaine (McBride & Inciardi, 1990).
The propensity for crime-prone, drug-using people to commit property or violent
crimes might be expressed only after they cross the threshold from use to abuse or
dependence. For example, criminal activity is substantially greater among frequent drug and
polydrug users (i.e., users of two or more substances at the same time) than among sporadic
drug users or nonusers (Wexler, Lipton, & Johnson, 1988). Thus, drug-using offenders,
especially those with substance abuse and dependence problems, commit both a greater
number and a greater variety of income-generating crimes as well as engage in higher rates
of crimes than offenders without drug-use problems (Dembo, Williams, & Schmeidler,
In 2004, among all state and federal prison inmates nationwide, nearly 20 percent
reported that they had committed their current offense to obtain money to buy drugs. State
prisoners who committed property (30 percent) or drug crimes (26 percent) were more likely
than those who committed violent (10 percent) or public-order crimes (7 percent) to report
that they committed their current crimes to obtain money to purchase drugs (Mumola &
Karberg, 2006). One quarter of convicted jail detainees who had been convicted of property
or drug offenses reported that they committed their current crimes to obtain money to
purchase drugs, compared to 5 percent each of jail detainees who were convicted of violent
or public-order offenses (Karberg & James, 2005).
Systemic model. The systemic violence of the drug trade was first recognized as a
serious problem in 1985 when crack cocaine sales became widespread in major metropolitan
areas such as New York City and Washington, D.C. Well-armed and violent drug dealers led
the struggle to protect and gain control over initially unstable, highly lucrative drug markets.
At that time, the proliferation of automatic weapons made drug violence even more lethal.
When the drug markets stabilized, homicide rates fell in most major cities (Lemmer,
Drug trafficking and violence are associated in several ways. The violence that
accompanies illicit drug use can occur because of conflicts that stem from competition
among drug sellers for drug markets and customers. Public drug selling in particular is
associated with high rates of violent crime. Furthermore, disputes and “rip offs” in drug-cash
transactions can erupt among individuals involved in illegal drug markets; drug traffickers
frequently use violence to resolve such conflicts. Moreover, locations where street drug
markets proliferate tend to be economically and socially disadvantaged; legal and social
controls against violence in such areas tend to be ineffective (Goldstein, 1985). In 2005, the
Federal Bureau of Investigation reported that of the homicides in which the circumstances
were known, 4 percent were designated as drug-related murders that occurred during a
narcotics felony, such as drug trafficking or manufacturing (Federal Bureau of Investigation,
2005). Other types of violence are a direct result or byproduct of the illegal drug trade,
including the robbery of drug sellers who then retaliate, the killing of drug informants and
witnesses, and violent altercations between buyers and sellers over debts or the quality of
purchased drugs (Lyman & Potter, 2003).
Drug Treatment: Types, Effectiveness, and Principles Types of Drug Treatment: A Brief Overview
As mentioned previously in this report, addiction is a recurring disease that often
requires repeated episodes of treatment. The ultimate goal of treatment is sustained
abstinence. During the process of recovery, treatment is designed to improve overall
functioning while minimizing the social and medical consequences of substance abuse and
dependence disorders. The recovery process begins with treatment and progresses as addicts
gain insights into their uncontrolled use of alcohol and drugs and start to manage their
thoughts, feelings, and behaviors (Center for Health and Justice, 2006).
The course of treatment for drug-dependent persons follows a general therapeutic
process and lies on a continuum of care (NIDA, 2006b). Drug treatment encompasses a broad
range of services, including detoxification, educational and vocational training, urine testing,
counseling, HIV education and prevention, life and interpersonal skills training, psychiatric
care, pharmacotherapy, psychotherapy, relapse prevention strategies, and self-help groups (see
section on drug treatment principles below) (Anglin & Hser, 1990; Hoffman & Fromeke,
2007; Peters, 1993). Depending on the nature and severity of the addiction and an
individual’s progress toward recovery, treatment can occur at various levels and in diverse
settings: inpatient, intensive outpatient, outpatient, or sobriety maintenance (Center for
Health and Justice, 2006). NIDA (2006b) classifies treatment into two broad categories:
The use of medication in recovery typically begins during detoxification. Persons
who are physically dependent on alcohol and drugs are placed on medications to safely
alleviate the painful symptoms and control the adverse physical consequences of withdrawal.
Medication is used in the treatment and relapse prevention process to “help re-establish
normal brain function and to prevent relapse and diminish [drug] cravings” (NIDA, 2006b, p.
3). For example, buprenorphine and methadone effectively treat opiate addiction by blocking
withdrawal symptoms and reducing drug cravings. The passage of the Drug Addiction
Treatment Act in 2000, permits physicians to prescribe these medications in medical settings;
previously, such medications could be dispensed only in specialized drug treatment clinics.
Promising new medications for drug addiction are pending FDA approval, including
Baclofen (for cocaine addiction), Nalemfene (for opiate addiction), Topitamate (for alcohol,
opiate, and cocaine addiction), and Disulfiram (for cocaine addiction [although for many
years used for alcohol addiction]) (Hoffman & Fromeke, 2007).
Behavioral therapy consists of interventions designed to change addicts’ attitudes and
behaviors as well as help them acquire the skills and competencies they need to avoid
relapses. Several behavioral approaches have proved successful in treating addicts—used by
themselves or in combination with medications. The most common are cognitive behavioral
therapy (helps addicts avoid relapse triggers), multidimensional family therapy (focuses on
adolescents and their peers and family members), motivational enhancement therapy
(capitalizes on addicts’ readiness to change their behaviors and begin treatment), and
motivational incentive therapy (employs positive reinforcement and contingency
management techniques to promote abstinence) (NIDA, 2006b).
Abundant research demonstrates that drug treatment reduces illegal drug use, crime,
and recidivism in the general and correctional population (Anglin & Hser, 1990; Anglin et al.,
1996; Gerstein & Harwood, 1990; Office of Technology Assessment, 1990). Since the 1960s,
numerous studies at the local, state, and federal levels have shown that drug treatment works
(Lurigio, 2000). The best research on drug treatment consists of large-scale, federally funded
studies that involve large samples of participants and employ longitudinal designs and a
comprehensive range of outcome measures. These studies have provided the most
compelling evidence that addiction is a treatable disease and have identified the principles of
drug treatment that characterize the most useful and effective programs (see below).
Large-Scale Studies of Drug Treatment
Three large-scale, multisite investigations, funded by NIDA, strongly support the
conclusion that drug treatment works: the Drug Abuse Reporting Program (DARP), the
Treatment Outcome Prospective Study (TOPS), and the Drug Abuse Treatment Outcome
Study (DATOS). These evaluations of community-based treatment have contributed greatly to
our knowledge about the benefits of drug treatment and significantly influenced drug
treatment policies, programs, and research (Gerstein & Harwood, 1990; McLellan, Metzger;
Alterman, Cornish, & Urschel, 1992; Simpson, Chatham, & Brown, 1995). As Lillie-Blanton
(1998) stated, "these studies are generally considered by the research community to be the
major evaluations of drug abuse treatment effectiveness, and much of what is known about
'typical' drug abuse treatment outcomes comes from these studies" (p. 3).
Drug Abuse Reporting Program. DARP involved more than 44,000 persons admitted
to drug treatment between 1969 and 1973. Participants were in 52 federally funded treatment
programs that administered four types of treatment modalities: methadone maintenance,
therapeutic communities, outpatient drug-free treatment, and detoxification. Conducted by
researchers at Texas Christian University, data were collected through client interviews with
treated clients and persons who applied for treatment but never returned for services (intake-
only clients). Information was also collected from clients' progress reports and other program
records. Follow-up intervals occurred from 3 to 12 years after treatment. “The DARP
findings have been widely used to support continued public funding of drug-abuse treatments
and to influence federal drug policy in the United States” (DARP, 2007, p.3)
DARP found that clients’ daily use of opiates declined from 100 percent prior to
treatment to 36 percent in the first year after treatment and 24 percent 3 years after treatment.
In the DARP study, addicts who were in treatment for more than 90 days were significantly
less likely to use drugs in the year after treatment than those who were in treatment for fewer
than 90 days (Simpson & Sells, 1982). Outpatient drug-free treatment, methadone
maintenance, and therapeutic communities were equally effective at producing positive
outcomes; clients in detoxification programs or those who dropped out of treatment within 3
months showed no positive outcomes. Moreover, among drug treatment clients in general,
arrest rates declined 74 percent and employment rates increased 24 percent after treatment.
Twelve years after treatment, daily heroin use remained 74 percent lower (Simpson, 1993;
of the opiate addicts studied in DARP reported at least
one relapse to daily use after they had experienced a period of sobriety. The highest
percentage of addicts (85%) who quit using drugs, did so while in treatment. The most
common reasons reported for staying sober referred primarily to the adverse consequences of
addiction. For example, 83 percent of the treatment participants indicated that they quit
because they were “tired of the hustle,” 56 percent, because they were “afraid of going to
jail,” and 54 percent, because they had to “meet family responsibilities” (Simpson & Sells,
Treatment Outcome Prospective Study. TOPS involved 11,000 people admitted from
1979 through 1981 to 41 drug treatment programs in 10 cities. Three types of programs were
examined—outpatient drug free, residential, and methadone maintenance—and clients were
followed 1, 2, and 3 to 5 years after treatment. TOPS found that drug treatment reduced drug use
for as many as 5 years after a single treatment episode; different treatment modalities appeared
to be equally effective in helping drug users recover. Declines in drug use were most dramatic
among heroin and cocaine users (Hubbard et al., 1989)
TOPS also produced solid evidence that drug treatment reduces drug users' criminal
activities. Three to 5 years after treatment, the proportion of clients engaged in pretreatment
predatory crimes decreased by one-third to one-half among the three treatment modalities.
Moreover, TOPS demonstrated that drug treatment is cost-effective and cost-beneficial; data
showed that the costs of treatment were recouped largely during treatment and that additional
cost savings accrued with reductions in post-treatment drug use. Criminal justice savings were
significant. Researchers reported a 30 percent decline in costs to victims of drug-related
crimes and a 24 percent decline in costs to the criminal justice system (Harwood, Collins,
Hubbard, Marsden, & Rachal, 1988). TOPS' principal investigators, Hubbard et al. (1989),
concluded that "publicly funded drug abuse treatment is essential to our national effort to
reduce the demand for drugs and its related social and economic costs" (p. 12)
Drug Abuse Treatment Outcome Study. DATOS, the third NIDA-funded compre-
hensive evaluation of drug abuse treatment (Leshner, 1997), followed a sample of 10,000
clients in 96 programs located in 11 large- and medium-sized cities in the United States for
36 months, from 1991 through 1993. DATOS participants were selected from four treatment
programs: outpatient drug-free, outpatient methadone maintenance, short-term inpatient, and
long-term residential. According to Leshner (1997), DATOS was “the first national study
of treatment outcomes since the AIDS epidemic began, the first to examine outcomes for
community-based cocaine abuse treatment, the first since the transition to NIDA block grants
in 1981, and the first to include public and private short-term inpatient hospitals as a treatment
modality” (p. 211) (also see Hubbard, Craddock, Flynn, Anderson, & Etheridge, 1997).
DATOS found that a larger percentage of drug-free outpatients than similar
TOPS participants were involved in the criminal justice system and that clients with
psychiatric disorders were more likely to be polydrug users (Flynn, Craddock, Luckey,
Hubbard, & Dunteman, 1996). Drug treatment significantly reduced drug use from
pretreatment baseline levels to 12-month post-treatment levels for persons addicted to heroin,
cocaine, and other types of drugs (Hubbard, et al., 1997; Simpson, Joe, & Brown, 1997).
DATOS also found that ancillary services for addicts had declined, but drug treatment
programs were delivering core services (i.e., assessment, treatment, and aftercare) more
effectively than they had in the DARP and TOPS studies (Etheridge, Hubbard, Anderson,
In a five-year study of cocaine addicts, DATOS researchers reported that treatment
reduced cocaine use from 100 percent at intake to 25 percent 5 years after discharge from
treatment. Illegal activity declined from 40 percent in year 1 post-treatment to 25 percent in
year 5 post-treatment. In general, the study found that clients with more serious drug and
psychosocial problems at intake had poorer outcomes in treatment. However, more exposure
to treatment was related to more positive long-term outcomes (Simpson, Joe, & Broome,
National Treatment Improvement Evaluation Study
Another federally funded, national evaluation of drug treatment was the National
Treatment Improvement Evaluation Study (NTIES). Funded by the Center for Substance
Abuse Treatment and conducted by the National Opinion Research Center and the Research
Triangle Institute, NTIES used a highly rigorous methodology and extensive outcome
measures. The purpose of the project was to investigate the impact of drug treatment on more
than 4,000 clients in publicly supported drug treatment programs across the country.
NTIES found that drug treatment had numerous favorable effects on clients, including
reductions in drug use. For example, one year after treatment, clients’ use of heroin dropped
from 73 to 38 percent while cocaine use dropped from 40 to 18 percent. The study also found
post-treatment reductions in arrests rates, self-reported criminal activities, drug selling, and
illegal earnings. Among treatment participants, homelessness, unemployment, and welfare
dependency declined while overall physical and mental health problems became less severe.
Moreover, participants engaged in safer sex practices after drug treatment than before;
specifically, the percentage of participants who reported having sex for money declined 56
percent, and the number who had sex with an intravenous drug user declined 51 percent
(Substance Abuse and Mental Health Services Administration, 2007).
The Services Research Outcome Study (SROS), conducted by the Substance Abuse
and Mental Health Services Administration (SAMHSA), was the first nationally
representative study of drug treatment in the United States. SROS involved 1,800 participants
in inpatient, outpatient, and residential care who were discharged in 1990 from a random
sample of 100 facilities in rural, suburban, and urban areas nationwide. Five years after
treatment, participants were interviewed; the results showed consistent reductions in drug use
—namely, 45 percent in cocaine use, 28 percent in marijuana use, 17 percent in crack
cocaine use, and 14 percent in alcohol and heroin use. The study also reported 23 to 38
percent reductions in criminal activity, such as burglary, the selling of drugs, and
prostitution. Finally, after completing drug treatment, participants were less likely to be
involved in physically abusive relationships or attempt suicide and were more likely to live in
Treatment in Correctional Settings
Correctional programs are often the only treatment opportunities for addicted
offenders who otherwise would not have access to such services (Wexler, Williams, Early, &
Trotman, 1996). Drug abuse programs in jails and prisons primarily treat offenders with the
most serious substance abuse disorders; such programs have several advantages over
community-based treatment programs for addicted offenders (Peters & May 1992; Wexler,
1995). For example, the participants in jail- and prison-based drug treatment programs have
relatively low drop-out rates and receive good-time incentives for their attendance in the
program—a strong motivator for retention (Tunis, 1995).
Drug treatment programs in correctional settings are generally located in the safest
and least-crowded areas in jails and prisons. As a result, even offenders with low motivation
for drug treatment are likely to remain in these programs long enough to benefit from the
experience. In addition, jail and prison inmates are already being housed; hence, residential
treatment, which is expensive provided on the outside, costs much less per capita when
implemented in jails or prisons. Finally, inmates in drug treatment are less likely to break
rules or to be involved in violent altercations than those in the general prison or jail
population. Therefore, jail and prison drug treatment programs help administrators better
manage and control their inmate populations (Early, 1998).
Drug treatment in prisons. In 1997, slightly more than one-third of state prisoners
nationwide reported previous participation in substance abuse treatment (e.g., detoxification,
in-patient treatment, or professional counseling), while more than 40 percent reported
previous participation in other types of substance abuse interventions (e.g., educational
awareness sessions, self-help groups, or peer counseling activities). Nearly 60 percent
indicated that they had previously participated in either or both types of programs.
Approximately half (48%) indicated that they had received drug treatment or other types of
addiction-related services while under correctional supervision; 32 percent indicated that they
were participating in drug treatment or other types of services while currently incarcerated.
Participation in drug-related interventions of any kind was higher among prison
inmates who reported that they were under the influence of drugs or alcohol at the time of
their most recent arrest as well as those who had six months or less to serve on their current
prison sentence. Prison inmates with the highest percentages of participation in current drug
treatment or other drug-related programs reported being under the influence of drugs or
alcohol at the time of their most recent offense. Within that group, 18 percent were receiving
current treatment, 32 percent were receiving other drug-related services, and 39 percent were
receiving either or both (Mumola, 1999).
From 1991 to 1999, the percentage of inmates who participated in prison-based
treatment during their present incarceration declined significantly from 24 to only 10 percent.
Among state prisoners who reported regular drug use prior to incarceration, 34 percent
indicated that they were currently participating in prison-based drug treatment in 1991; in
1997, that percentage dropped to 14 percent. However, from 1991 to 1997, the percentage of
inmates who reported present involvement in other types of drug programs increased slightly
from 15 to 20 percent among all inmates, and from 22 to 26 percent among inmates who
Therapeutic community. One of the most common, studied, and successful prison-
based drug treatment programs is the therapeutic community (TC) (Mitchell, MacKenzie, &
Wilson, 2006). The term “therapeutic community” has been used to describe treatment in
various drug-free residential settings, including prisons, jails, camps, ranches, group homes,
and special schools, and for various conditions, including psychiatric problems, alcoholism,
and drug abuse and dependence disorders (Lipton 1998). In the United States, TCs focus
mostly on the rehabilitation of drug addicts in prisons and secured community-based settings.
The typical TC participant has multiple addictions, comorbid psychiatric disorders, a history
of criminal involvement, and a paucity of human and social capital (NIDA, 2002).
TC interventions are directed at the whole person rather than concentrating on the
individual’s criminal tendencies or drug abuse problems (NIDA, 2002). The key instrument
or agent of change is the community itself and “recovery involves persons interacting with
the community in a process of ‘curing’ themselves” and taking responsibility for their own
rehabilitation (Lipton, 1998, p. 34). TCs are administered by a hierarchical “community of
peers,” role models, or surrogate family members not by clinicians or other professionals.
The intensive and highly regimented atmosphere of the TC is permeated by immutable
behavioral norms that encourage resocialization, total lifestyle changes, and correctives in
residents’ thinking, feeling, and moral decision- making. The hierarchical structure of the TC
helps develop residents’ self-discipline and –control, and redirects their energies away from
criminal behavior and drug use and toward more productive prosocial pursuits, such as
sporting, religious, or work activities (Lipton, 1998).
The TC’s daily schedule is regimented; residents’ time is spent participating in group
sessions, community meetings and seminars, vocational and educational classes, and
fulfilling communal responsibilities, such as maintaining the physical and programmatic
integrity of the community. Treatment in the TC usually follows invariant stages, namely,
induction (i.e., acclimating to the environment, learning the rules of the community, and
committing to the recovery process), primary treatment (i.e., participating in social,
psychological, and educational interventions), and re-entry and structured aftercare services
(i.e., preparing for transition to larger society) (NIDA, 2002). “Elements of TCs (e.g.,
encounter groups, rule setting and rule enforcement, rewards, and work) allow clients to
learn—often for the first time—interpersonal, educational, and vocational skills and to
develop psychological, moral and social strengths” (Office of National Drug Control Policy,
Several investigations in Delaware, Texas, and California have found that, compared
to control samples, graduates of TCs have lower rates of rearrest, relapse, and reincarceration
(Knight, Simpson, & Hiller, 1999; Martin, Butzin, Saum, & Inciardi, 1999; Wexler, Melnick,
Lowe, & Peters, 1999). Delaware’s KEY/CREST program is widely regarded as an
exemplary prison-based TC. The program consists of three major stages of care: primary
(i.e., orientation and treatment services in the institution), secondary (i.e., a transitional
services in a work-release setting), and tertiary (i.e., aftercare services and reentry planning
in the community in a supervisory program).
An evaluation of KEY/CREST, which followed a cohort of 690 residents for five
years post-release, found that participants were more likely than controls to remain drug- and
arrest-free. The success rates in avoiding criminal recidivism and relapse to illicit drug use
were highest for program completers who had aftercare services, followed by program
completers with no aftercare services, program drop-outs, and no-treatment control group
inmates (Inciardi, Martin, & Butzin, 2004). However, in a three-year follow-up study of TC
participants and a comparison group of inmates in a prison-based TC in Pennsylvania, Welsh
(2007) found that the program was effective in reducing rearrest and reincarceration rates but
not relapse rates. Furthermore, he reported that post-release employment reduced rearrests
for older, but not younger, ex-offenders.
Drug treatment in jails. In 2002, nearly two-thirds (63%) of substance-abusing or
dependent jail inmates reported that they were presently participating in drug treatment
programs; 30 percent were in residential facilities, professional counseling sessions, and
detoxification units or in other drug-related interventions, and 36 percent were in educational
classes or self-help groups or both. Previous participation in drug treatment and other drug-
related services was higher for substance-dependent jail inmates (63%) than for substance-
abusing jail inmates (52%). Irrespective of whether they were drug-dependent or -abusing,
jail inmates with previous treatment experiences in correctional settings were more likely to
receive such services while on probation or parole (25%) than while in jail or prison (20%).
From 1996 to 2002, the percentage of jail inmates reporting participation in drug programs in
correctional settings increased slightly in three categories of substance use: from 39 to 47
percent among regular users, from 39 to 47 percent among those who used in the month
before their most recent offense, and from 43 to 52 percent among those who were using at
the time of their most recent offense (Karberg & James, 2005). At the preadjudication stage,
the drug treatment participation of jail detainees can be abruptly terminated when their cases
are called to court for disposition. In those instances, treatment is terminated on the basis of
administrative rather than clinical considerations and can be highly disruptive to the recovery
process. Most problematic is that such truncated treatment is rarely followed by appropriate
or timely community-based care (Lurigio & Swartz, 1994).
Drug treatment in probation. In 1995, more than one in five probationers (22%)
reported previous participation in drug treatment. The most common types of services were
outpatient care (17%) and self-help groups (14%); the least common were crisis intervention
and inpatient care (8% each). The highest percentages of probationers with drug treatment
histories reported that they used drugs in the month prior to their most recent offense (51%),
followed by those who used drug regularly (46%), and those who used drugs ever (32%).
Less than one in five probationers (17%) indicated that they were currently
participating in probation-based drug treatment or other type of addiction-related program.
Half of all probationers reported that they were tested for drug use during their present
sentence. The percentage of probationers in current drug treatment was highest among those
who reported that they had ever used a needle to inject drugs (62%), followed by those who
used drugs at the time of their most recent offense (53%), those who committed their most
recent offense to get money to buy drugs (48%), those who used drugs in the month before
their most recent offense (42%), those who used drugs regularly (36%), and those who used
drugs (25%) ever (Mumola & Bonczar, 1998).
Numerous studies have demonstrated the cost-effectiveness and cost-benefits of drug
treatment (Center for Health and Justice, 2006). The economic benefits of drug treatment
accrue mostly from reductions in incarceration, criminal victimization, medical treatment,
and lost wages (Hoffman & Fromeke, 2007). A recent study in California found that the state
saved 7,500 dollars in aggregate reductions in crime and incarceration for every person
treated (Ettner, Huang, Evans, Ash, Hardy, Jourabchi, & Hser, 2007). Similarly, another
study found that every dollar spent on drug treatment resulted in an average of 7 dollars in
savings stemming from decreased crime and its corollaries (e.g., increased employment and
major reductions in healthcare expenditures) (McCarthy, 2007).
In an extensive review of hundreds of studies of drug treatment programs, Belenko,
Patapis, and French (2005) found drug treatment to be effective in reducing drug use and
crime while improving the health and social functioning of persons in recovery, especially
those who participated in programs with evidence-based practices. Furthermore, the authors
found that drug treatment yielded robust economic benefits arising from savings in the costs
of crime, incarceration, and victimization as well as reductions in health care expenses and
other medical costs. Belenko et al. concluded that “it is clear from research on the economic
impacts of substance abuse and addiction on health, crime, social stability, and community
well-being that the costs to society of not (authors’ italics) treating persons with substance
abuse problems would be quite substantial” (p. 58).
Principles of Effective Drug Treatment
Several basic principles underlie and characterize successful drug treatment practices.
These principles have largely been derived from studies of whether and how drug treatment
works to change addicts’ behaviors; many of these studies were discussed earlier in this
report (Anglin et al., 1996, 1998; Prendergast, Anglin, & Wellisch, 1995; Taxman & Spinner,
1997). With funding and guidance from NIDA, researchers explored the implementation of
drug treatment programs and their effects on a variety of populations. Their aggregate
findings led to the identification of core program elements that assist addicts in achieving
sobriety and improving their lives in many areas of functioning (NIDA, 1999; 2006a). The
following is a synthesis and distillation of NIDA’s principles of effective drug-treatment
Drug Assessment and Treatment Matching
The first principle is that no single drug treatment regimen is useful for all addicts
(NIDA, 1999). To develop successful treatment approaches, tailored to each client’s addiction
and service needs, clinical evaluations must be conducted to assess the specific nature and
extent of clients’ substance use disorders. The fundamental clinical question is what type of
treatment or intervention is most appropriate for what type of client, in which type of setting,
and for what length of time (NIDA, 1999).
A crucial first step in the formulation of an individualized treatment plan is the use of
comprehensive and standardized assessment protocols that collect accurate information about
a client’s current and previous drug use; criminal history; medical conditions; drug and
psychiatric treatment experiences; education and employment records; cognitive,
psychological, and interpersonal adjustment; and social support networks (Anglin et al.,
1996). Before treatment begins, a client’s readiness and motivation for change must also be
At intake, clients should be tested for communicable diseases (e.g., HIV/AIDS,
tuberculosis, and Hepatitis B and C), which are significantly more prevalent among people
who use drugs (NIDA, 2006a). If they test positive, clients should be counseled on treatment
options and the importance of avoiding behaviors that can spread infections to others. If they
test negative, clients should be counseled on ways to prevent infection through safer sex and
drug-use practices (so-called harm reduction strategies) as they strive for recovery.
Following assessment, clients’ problems and needs should be matched to treatment
settings and strategies (NIDA, 1999). Addicts who openly acknowledge their drug problems
and commit fully to the recovery process can benefit greatly from drug treatment and
adjunctive social and medical services (Simpson, 1998b). Repeated, unfavorable
consequences from substance abuse can lead addicts to realize that professional interventions
are necessary to achieve sobriety (Hoffman & Fromeke, 2007). Thus, addicts with extensive
drug use and criminal histories are often amenable to treatment (Anglin et al., 1996).
Clients in the early stages of drug use can also be excellent candidates for drug
treatment programs (Center for Substance Abuse Treatment, 1994). With the implementation
of proper assessment and treatment-matching techniques, most persons with substance use
disorders can be helped by treatment at any juncture in their addiction careers. The old adage
that drug abusers must “hit rock bottom” before they can begin recovery is supported by
neither research nor clinical experience (Hoffman & Fromeke, 2007).
Availability and Length of Participation
The second principle is that effective treatment takes time and must be highly
accessible and readily available to take advantage of addicts’ readiness for change (NIDA,
1999). People with substance use disorders can lose their interest and willingness to enter
treatment when they languish on waiting lists for services. Drug users must break through
their denial and hesitancy and become motivated in the early stages of the recovery process,
paving the way for long-term care (Anglin et al., 1996). Motivational interviewing
techniques can be quite effective in encouraging engagement in the initial phases of
Treatment takes time. Addiction is an intractable disease and cannot be overcome with
brief interventions. Hence, the goal of treatment should be the management of addiction, not
its cure. Many studies show that the length of stay in treatment is positively related to
outcomes (De Leon, 1991; Simpson, 1979, 1998a; Simpson, Joe, Lehman, & Sells, 1986).
However, clients frequently leave drug treatment prematurely; therefore, different strategies
must be used to engage and retain addicts in services long enough for them to gain
therapeutic benefit from their participation. The threshold for achieving significant
improvement in treatment is generally reached in three months, and several episodes of
treatment, aftercare, and relapse are expected before abstinence is attained (Gendreau, 1996;
Wexler, Falkin, Lipton, & Rosenblum, 1992).
Fletcher, Tims, and Brown (1997) observed that the "association between treatment
duration and outcomes is strong enough to warrant research simply to improve retention.”
Furthermore, they stated that "time itself is a surrogate measure that might represent, for
example, motivation, willingness to adhere to treatment, a process of behavioral change, or
the ability of the practitioner to engage the patient" (p. 223). Therefore, favorable treatment
outcomes depend not only on time spent in treatment but also on what happens during
treatment to change clients' behaviors (Anglin et al., 1996).
Recovery is a nonlinear process. Addicts learn to eschew old patterns of thinking
(e.g., criminogenic attitudes and beliefs) and behaving and to replace them with new
problem-solving skills for reducing cravings, avoiding relapse triggers (i.e., places, persons,
and paraphernalia that remind the addict of drug use), and re-establishing healthy
interpersonal relationships. Recovery involves steady progress toward a responsible,
abstinent, and productive life (NIDA, 2006a).
The third principle is that treatment should be both highly structured and adaptable,
involving medical detoxification for persons with a substance dependence disorder and a
contingency management component for all clients. Detoxification safely alleviates the acute
physical symptoms of withdrawal and is a necessary (but not sufficient) precursor to successful
drug treatment. Under a physician’s care, detoxification is conducted in a hospital or residential
setting and lasts from three to five days (Hoffman & Fromeke, 2007; NIDA, 1999). After a
client becomes stabilized through detoxification, progressive incentives can be incorporated
into treatment. Different types of contingency contracts include positive and negative
reinforcements to encourage addicts to remain drug free and engaged in the therapeutic
process (Onken, Blain, & Boren, 1997). Voucher-based incentives can be combined with
nonmonetary rewards, such as verbal recognition, reward ceremonies, and certificates of
Graduated sanctions should be leveled against participants who do not adhere to
program regulations, and rewards should be given to those who do. To be most effective, positive
and negative sanctions must be clearly specified, explicitly tied to behaviors, and swiftly
administered (NIDA, 2006a). They should also be progressive and commensurate with the
severity of clients’ rule breaking or their degree of improvement. Clients should be monitored
throughout treatment to overcome their struggles to identify and avoid the triggers for
relapse. The continued use of drugs should be tracked through urinalysis or other objective
Treatment success depends on the adaptability of services in meeting addicts’
changing life circumstances (McLellan, Arndt, Metzger, Woody, & O'Brien, 1993).
Interventions are most effective when they are responsive to addicts' evolving needs at
different points in the recovery process (Anglin et al., 1996). Treatment and service plans
should be continually renewed and modified throughout recovery. They must always be
sensitive and responsive to differences in clients’ age, gender, race, ethnicity, and sexual
orientation. Practitioners should be skilled at combining several modalities, including
medication, individual and group psychotherapy, family interventions, childcare assistance,
Medications, such as methadone, LAAM, Naltrexone, and bupropion, can be essential
aspects of care, especially when administered with psychotherapy and other supportive
interventions (NIDA, 1999). In addition, “self help can complement and extend the effects of
professional treatment” (NIDA, 1999, p. 20). Self-help interventions include 12-step
programs (e.g., Alcoholics Anonymous, Narcotics Anonymous, and Cocaine Anonymous)
Drug treatment programs must be flexible in their responses to relapses—expected,
not exceptional, setbacks on the pathway to sobriety. Relapses can occur even after
prolonged periods of abstinence, although addicts are most vulnerable to relapse in the first
three to six months after treatment (Hoffman & Fromeke, 2007; NIDA, 2006a). Occasional
drug use by participants, which minimally disrupts the recovery process, should be handled
immediately through placement in detoxification, exposure to graduated sanctions, or return to
a higher level of care. As a rule, one or two minor relapses should not result in participants
being summarily dropped from drug treatment programs as the termination of treatment after
relapse is ill-advised, unjustified, and unethical from a medical standpoint (Hoffman &
Addicts who are coerced into drug treatment by legal mandates are just as successful
in recovery as those who enter treatment programs voluntarily, and legally coerced
participants typically remain in treatment programs longer (Anglin et al., 1990). Whenever
possible, legal mandates should be used to order offenders to participate in drug treatment
programs and to hold them accountable for their progress in recovery (NIDA, 2006a).
Coercion involves entering and complying with drug treatment or facing legal
consequences. Participation is mandatory and noncompliance can result in sanctions, such as
incarceration, the loss of child custody rights, or more stringent conditions of community
supervision. Coerced treatment can be mandated at various stages of the criminal justice
process and imposed with varying degrees of restrictiveness. Judges can offer a defendant the
choice between treatment and incarceration. Probation officers can recommend and enforce
treatment as a court-ordered condition of probation. Prison administrators can place inmates
involuntarily into drug treatment programs (Lurigio, 2002).
A willingness to enter treatment is not a prerequisite for success (Hoffman &
Fromeke, 2007). Legal coercion compels addicts make decisions that they might not be able
to make on their own. Coercion is leverage that keeps addicted offenders in treatment long
enough to benefit from the positive effects of a supportive therapeutic experience and
become intrinsically motivated to remain and succeed in care. In short, coerced treatment
provides services for addicts that would otherwise have been unavailable to them (Lurigio,
The fourth principle is that drug treatment must be evidence-based (science-validated)
and implemented in accordance with proven models of recovery (Hoffman & Fromeke,
2007). Evidence-based practices are never grounded in a drug treatment agency’s traditions
or the experiences or preferences of its staff; instead, they are supported by independent
research that demonstrates their effectiveness in achieving outcomes that are broadly
endorsed by experts and practitioners in the addiction field (Lurigio, 2006). As Brady states
Evidence-based treatment is treatment that has been proven to work through rigorous scientific studies. Evidence-based treatment is particularly important in the addictions field because many myths and personal biases have infiltrated the treatment area and are often accepted without question.
The most compelling evidence of a program’s effectiveness emerges from research
that includes representative samples of participants, random assignment to treatment and
control groups, and baseline and follow-up measures of client performance that are valid
(accurate) and reliable (consistent). Moreover, the most useful results of studies—for the
purpose of establishing evidence-based practices—are based on evaluations of programs that
are manualized and implemented by trained, credentialed, and experienced staff persons.
Practitioners must implement treatment protocols carefully and consistently, and participate
regularly in professional development activities (Lurigio, 2006). Evidence-based drug
treatment services include: relapse prevention therapy, supportive-expressive psychotherapy,
individualized drug counseling, motivational enhancement therapy, multidimensional family
therapy for adolescents, and the matrix model (NIDA 1999).
The fifth principle is that people with substance use problems should receive services
that address their other difficulties (NIDA, 1999). Drug abusers tend to suffer from a variety
of psychological, medical, and social problems as well as deficits in education, employment,
and housing (Swartz & Lurigio, 1999b). Many of these problems persist throughout the
recovery process (McLellan, et al., 1981). Drug treatment practitioners should collaborate
with other service providers (e.g., psychiatrists and psychologists, vocational training experts,
and housing advocates) in addressing the multifaceted problems of drug addicts, especially
those with comorbid psychiatric disorders who need integrated substance use and psychiatric
treatment services. Addicts must be treated comprehensively; their various problems should
be addressed simultaneously, not sequentially (Waller & Weiner, 1989).
The sixth principle is that residential (short- or long-term) treatment must be followed
by a continuum of care, namely, intensive outpatient treatment, aftercare, and relapse
prevention services. Seamless interventions are instrumental in achieving sobriety (NIDA,
1999; Russell, 1994). As mentioned throughout this report, drug abuse and dependence
disorders are chronic, and several cycles of treatment and aftercare services—often “with a
cumulative impact”—are required to minimize relapses and sustain recovery (NIDA, 1999, p.
16). If drug abusers remain in intensive treatment for at least 90 days and receive continuous
care after treatment, they are more likely to attain sobriety, get a job, and stop committing
Continuity of care is particularly crucial to the recovery of drug-involved offenders
leaving correctional settings (NIDA, 1999; Peters, 1993). Offenders who complete
structured drug treatment programs in jails or prisons should be assisted in their transition
to community-based services by engaging in prerelease planning and programming activities.
Without aftercare services (i.e., continuity of care), the gains that offenders make in prison or
jail treatment programs are frequently diminished or lost altogether (Lipton, 1995; NIDA,
Prison inmates who participated in a TC and follow-up TC treatment in work release
centers demonstrated significantly lower drug use and recidivism rates than those who
participated in institutional treatment only (Inciardi, 1998). Similarly, offenders participating
in both prison- and community-based TCs were less likely to commit subsequent crimes than
offenders who participated in drug treatment without follow-up care (Wexler, 1996; Wexler,
De Leon, Thomas, Kressel, & Peters, 1999).
Numerous obstacles can impede the delivery of aftercare services, including the
fragmented nature of the criminal justice system, the lack of coordination between criminal
justice practitioners and treatment providers, and the absence of incentives and
sanctions for offenders to remain drug free after unsupervised release from jails and prisons.
The paucity of community treatment programs and treatment providers' inexperience with
offenders are also impediments to recovery (Field, 1998). Relapse prevention services for
offenders should be more thoroughly studied and understood (Vigdal, 1995) as suggested by
the following under-investigated and unresolved issues:
• Reasons why offenders are especially vulnerable to relapse, including stressors related to
release from correctional facilities and psychosocial factors related to crime and drug
• The evolving recovery process at its various stages;
• The destabilized and stabilized relapse-prone individual;
• Methods to overcome recovery plateaus;
• Basic components of relapse prevention therapy (e.g., self-knowledge and
identification of warning signs, coping skills and management of warning signs, and
involvement of family members and others in the relapse prevention plan; and
• The timing of relapse prevention efforts, particularly in advance of release from jail and
The seventh principle is that drug treatment programs for offenders work best when
criminal justice professionals (e.g., probation, parole, and detention officers) and service
providers communicate with one another and coordinate their efforts (NIDA, 2006a). Cross-
training can help both groups understand the competencies and limitations of the other and
work more effectively as a case management team. As stated in NIDA (2006a), “The
coordination of drug abuse treatment with correctional planning can encourage participation
in drug abuse treatment and can help treatment providers incorporate correctional
requirements as treatment goals.” (p. 3)
Treatment Alternatives for Safe Communities (TASC) was the culmination of a federal
effort to establish and promote coordination between criminal justice agencies and treatment
providers at the local level. Seeded in 1972 with funding from the Law Enforcement and
Assistance Administration, TASC’s first pilot program was implemented in Wilmington,
Delaware. By 2007, more than 220 TASC programs were operating in 30 states. TASC
identifies, assesses, and refers offenders at the pretrial and post-adjudication levels to
treatment and adjunctive services. TASC monitors clients' treatment progress through case
management, urine testing, and other techniques, and reports violations of the conditions of
Case managers establish linkages between treatment providers and correctional staff
in order to develop coordinated strategies that hold offenders accountable and protect
community safety (Anglin et al., 1996; Inciardi & McBride, 1991; Swartz, 1993; Weinman,
1990). The critical elements of TASC operations include “a process to coordinate justice,
treatment, and other systems; procedures for providing information and cross-training to
justice, treatment, and other systems; policies and procedures for regular staff training;
clearly defined client eligibility criteria; and performance of client-centered case
The eighth principle is that drug treatment programs should be routinely examined by
outside evaluators to determine whether services are being implemented as planned (treatment
fidelity) and to measure the overall impact of services (treatment effectiveness). Process
evaluations should provide program staff members with real-time information that can be
used to improve service delivery and preserve treatment integrity. Outcome evaluations
should be based on internally valid research designs that incorporate random assignment and
control groups; such designs yield data that permit confident conclusions about program
effectiveness. Researchers should also consider client selection criteria and attrition (i.e.,
program dropouts) when interpreting results.
Evaluations of program impact must include a variety of outcome measures, such as
number and type of drugs used; frequency of drug use; treatment retention; desistence from
criminal activities; length of time to relapse and rearrest; vocational skills; employment;
social, psychological, and family functioning; reliance on social service agencies; physical
and emotional health; HIV risk behaviors; and mortality rates (Anglin & Hser, 1990; Swartz,
1993; Vigdal, 1995). Finally, researchers should test different treatment modalities to
ascertain which approaches work best with which groups of clients; they should also employ
longitudinal and nested research designs to understand more precisely the effectiveness of
interventions as well as the trajectories of participants' addiction and criminal careers
The effectiveness of drug treatment transcends settings and populations; its practices
have been science-validated and its ability to save taxpayer dollars is incontrovertible.
Nonetheless, the revolving door of addiction, crime, and incarceration continues to spin,
especially for drug-involved minorities—a point made crystal clear in the current series of
reports. The door spins, in part, because of the firmly entrenched policy of criminalizing
addiction and the paucity of drug treatment programs for addicted offenders. Indeed,
treatment resources have never kept pace with the ever-increasing numbers of offenders with
substance use disorders (Office of Natural Drug Control Policy, 2001).
Braude, Heaps, Rodriguez, and Whitney (2007) have developed a sweeping No-Entry
Strategy (NES) to divert non-violent drug offenders in Illinois from prison and into
treatment. This public policy framework emphasizes the viability of treatment at every point
of contact in the criminal justice process—from arrest to release from prison. The NES is
fully supported by research and designated to enhance public safety and the quality of life in
communities throughout Illinois. The strategy is built on the following six core principles,
which are affirmed throughout this report.
Principle I: Addiction is a brain disease. Changes in brain chemistry and functions
are responsible for the chronicity of substance use disorders despite their adverse
consequences (e.g., declining health and the threat of incarceration). Therefore, public policy
initiatives to combat drug use, crime, and disproportionate minority confinement must first
recognize the powerful science of addiction and the paramouncy of treatment and recovery
management in combating addiction and its widespread negative repercussions.
Principle II: Drug use is correlated with crime. Drug use can intensify criminal
behavior, especially among offenders who commit crimes to generate the income they need
to purchase drugs. As use graduates to abuse and dependence, criminal activity increases in
both frequency and number. The link between drug use and crime provides a forceful
argument in favor of treatment as the best vehicle for achieving the goals of public health and
Principle III: Current laws and drug enforcement practices that encourage racial disproportionality in prison sentences for drug-law violations must be confronted head-on.
As noted in Lurigio (2006), the public nature of drug sales and the pervasiveness of drug-free
zones in African American communities have created a recipe for disparate minority
confinement. The constitutionality and fairness of drug-free zones and other statutes have
ravaged the African American community and must be challenged. In short, “public policies
must consider the implications of current laws, strategies, and practices that perpetuate
(racial) disparities and harm individuals, families and communities” (Braude et al., 2007, p
Principle IV: Sentencing statutes must be brought in line with an equitable dispensation of justice. Since the 1980s, drug laws in Illinois have become increasingly
harsh. Nearly one-fifth of all new prison sentences in Illinois are for low-level (Class 4)
felony possession charges (Illinois Department of Corrections, 2005). Because of “triggering
weights,” prison sentences for smaller amounts of drug possession have become longer and
have had a disproportionate impact on minority offenders. For example, the possession of
only a half gram of cocaine can result in a prison sentence that is comparable to the sentences
that are meted out for sexual assault. Furthermore, offenders who are sentenced for a higher
(i.e., more serious) class of felony are less likely to have access to drug treatment services.
Drug laws misguidedly assume that incarceration is effective in reducing crime without
addressing the root problem (i.e., addiction) that causes or encourages criminal behavior.
Principle V: Drug treatment saves money. Drug treatment for addicted offenders is a
highly sound investment, yielding substantial dividends in improved public health and safety.
The imprisonment experience is likely to produce people who are stigmatized,
disenfranchised, dispirited, and unemployable. They leave prison more inclined to resume
illicit drug use and criminal pursuits and, ultimately, they are reincarcerated. In contrast, drug
treatment is likely to produce people who are law-abiding, willing and able to attend school
and work, and engage in social and family networks that help sustain the recovery process.
“Public policymakers must recognize that incarceration of nonviolent, drug-involved
offenders is not an affective or efficient return on the investment of taxpayer dollars” (Braude
Principles VI: Treatment alternatives to incarceration enjoy a high level of voter support. National and statewide polls have demonstrated that voters recognize addiction as a
brain disease and drug treatment as a better option than incarceration for nonviolent drug-
involved offenders. Voters are also strongly in favor of treatment on demand for people with
substance use disorders. Collectively, these polls show that voters will stand behind
politicians who change onerous drug laws and provide more dollars for drug treatment and
recovery programs (Hart Research Associates and Coldwater Corporation, 2004; Illinois
Department of Human Services, 2003; Open Society Institute, 2002).
The preceding principles are the foundation for five majors NES recommendations
designed to reduce the number of incarcerated people for low-level, drug-law violations,
which would alleviate the problem of racial disparities in sentencing, to provide treatment for
drug-involved offenders in lieu of incarceration, and to save substantial tax payer dollars in
the process. These recommendations are as follows: 1) increase the state’s capacity to
provide community-based treatment for 25,000 nonviolent addicted offenders each year; 2)
appropriate 10 million dollars (in state fiscal year 2008) to lay the fiscal ground work for the
above treatment plan; 3) appropriate annual increases of 23 million dollars for the next five
years (in state fiscal years 2009 – 2013) to ensure the success and continuation of the
treatment plan; 4) rescind statutory provisions that limit access to drug treatment alternatives
but do not increase public safety risks; 5) stop legislating enhanced punishment for every
new drug that enters the market; and 6) require that any proposed penalty enhancements for
drug crimes be accompanied by a fiscal and community impact analysis (Braude et al.,
Approximately 20 million Americans reported illegal drug use in the previous
month—marijuana and cocaine were the most popular substances used—and nearly half of
all Americans reported that they used illicit substances during their lifetime. People use drugs
for different reasons—mostly because drugs improve their mood and performance. However,
drugs alter the chemistry and functions of the brain’s pleasure center and frontal cortex,
leading to the signs and symptoms of drug abuse and dependence, which are classified in the
psychiatric nomenclature as substance use disorders. Drugs can be grouped according to their
effects (e.g. stimulants, depressants, hallucinogens) or their legitimate medical use and
potential for abuse, as defined in the Controlled Substances Act.
Addiction is a chronic brain disease that affects millions of Americans and their
families and communities. A major threat to public health and safety, addiction costs billions
of dollars each year in terms of lost work productivity and healthcare expenditures. Current
and lifetime drug use are substantially higher in correctional populations (i.e., jail detainees,
prison inmates, and probationers) than in the general population. Large numbers of offenders
reported being under the influence of drugs when they committed their most recent crimes or
tested positive for one or more drugs at the time of their arrest. Those most likely to use
drugs also have other psychiatric disorders or histories of emotional, sexual, or physical
The relationship between drug use and crime is complicated, and many models have
been posited to explain their purported association. Some studies show that drug use causes
crime, others that criminal involvement causes drugs use, and still others, that crime and drug
use are concomitant aspects of a deviant lifestyle. Offenders can commit violent acts to
obtain money to purchase drugs; others commit violent acts as a part of the illicit drug trade
or because of the drug’s disinhibitory effects. Among criminally involved persons, drug use
intensifies criminal behavior whereas abstinence reduces it.
The best means to achieve abstinence is through drug treatment, which is effective in
reducing drug use and its consequences and corollaries, namely, crime, unemployment,
family dysfunction, and school failure. Treatment can be administered in various settings and
at different levels and is classified into two broad categories: medical and behavioral. Drug
treatment success has been demonstrated in several large-scale, federally funded
investigations that employed longitudinal designs and variety of outcome measures,
including DARP, TOPS, DATOS, NTIES, and SROS. Hence, the power of drug treatment to
change addicts’ lives has been demonstrated among different populations and settings and
reported in investigations that have employed a variety of methods, outcome measures, and
Several fundamental principles of effective drug treatment have been identified by
years of research and clinical expertise. The principles include treatment matching and
accessibility as well as the use of ancillary services to meet the wide ranging clinical and
habilitation needs of persons with substance use disorders. These principles also underscore
the importance of implementing a continuum of care that responds to the ever-changing
needs of addicts throughout the recovery process. Based on research and clinical experience
and focused on the attainment of equitable sentencing decisions, the no-entry public policy
framework recognizes addiction as a brain disease, recommends significant increases in
treatment resources to divert low-level, non-violent drug offenders from incarceration, and
argues for rational and race-neutral drug laws and enforcement strategies.
Abadinsky, H. (2007). Drug use and abuse: A comprehensive introduction. Pacific
Anglin, M.D., Brecht, M.L. & Maddahian, E. (1990). Pretreatment characteristics and
treatment performance of legally coerced versus voluntary methadone maintenance admissions
Anglin, M.D., & Hser Y. (1990). Treatment of drug abuse. In M. Tonry & J.Q.
Wilson (Eds.), Drugs and crime (pp.393-460). Chicago: University of Chicago Press.
Anglin, M.D., Longshore, D., Turner, S. McBride, D., Inciardi, J.A., & Prendergast,
M.L. (1996). Studies of the functioning and effectiveness of Treatment Alternatives to Street Crime (TASC) programs. Los Angeles: University of California, Los Angeles Drug Abuse
Anglin, M D., Prendergast, M .L., & Farabee. D (1998). The effect of coerced drug treatment for drug-abusing offenders. Paper presented at the Office of National Drug Control
Policy's Conference of Scholars and Policy Makers, Washington, DC.
Anglin, M.D. & Speckart, G. (1998). Narcotics use and crime: A multiple,
multiperiod analysis. Criminology, 26, 197-233.
Ball, J.C., Rosen, L., Flueck, J.A., & Nurco, D.N. (1981). The criminality of heroin
addicts: When addicted and when off opiates. In J.A. Inciardi (Ed.), The drugs-crime connection (pp. 39-65). Beverly Hills, CA: Sage.
Ball, J.C., Shaffer, J.W., & Nurco, D.N. (1983). The day-to-day criminality of heroin
addicts in Baltimore: A study in the continuity of offense rates. Drug and Alcohol
Braude, L. Heaps, M.M., Rodriguez, P., & Whitney, T. (2007). No entry: Improving public safety through cost-effective alternatives to incarceration in Illinois. Chicago: Center
for Health and Justice, Treatment Alternatives for Safe Communities.
Belenko, S., Patapis, N., & French, M.T. (2005). Economic Benefits of Drug Treatment: A critical review of evidence for policy makers. Philadelphia, PA: Treatment
Research Institute, University of Pennsylvania.
Bureau of Justice Statistics (2007). Crime characteristics. Washington, DC: United
Bureau of Justice Statistics. (2005). Drugs and crimes facts. Washington, DC: United
Center for Health and Justice. (2006). Understanding treatment and recovery.
Chicago, IL: Treatment Alternatives for Safe Communities.
Center for Substance Abuse Treatment. (1994). Screening and assessment for alcohol and
other drug abuse among adults in the criminal justice system (DHHS Publication Number SMA
Collins, James J., Jr., Hubbard, R.L, & Rachal, J.V. (1985). Expensive drugs use and
illegal income: A test of explanatory hypotheses. Criminology 23, 743-764.
Collins, James J., & Messerschmitt, P. M. (1993). Epidemiology of alcohol-related
violence. Alcohol Health and Research World 17, 93-100.
De Leon, G. (1991) Retention in drug-free therapeutic communities In R W Pickens, C. G.
Leukefeld, & C. R. Shuster (Eds.), Improving drug abuse treatment (pp 21-38) Rockville, MD:
Dembo, R., Williams, L., & Schmeidler, J. (1993). Addressing the problems of
substances abuse in juvenile corrections. In J.A. Inciardi (Ed.), Drug treatment and criminal justice (pp. 97-126). Newbury Park, CA: Sage.
Early, K.E. (1998, March). Correctional treatment: An effective model for Change.
Paper presented at the Office of the National Drug Control Policy’s Conference of Scholars
Elliot, D.S., Huizinga, D., & Ageton, S.S. (1985). Explaining drug use and delinquency. Beverly Hills, CA: Sage.
Erickson, Patricia G., and Valerie A. Watson. 1990. Women, illicit drugs, and crime.
In. In L. T. Kozlowski, H. M. Annis, H.D. Cappell, F. B. Glaser, M. S. Goodstadt, Y. Israel,
H. Kalant, E. M. Sellers, and E.R. Vingilis (Eds.), Research advances in alcohol and drug problemsVol.10. (pp. 143-157). New York: Plenum Press.
Etheridge, R.M., Hubbard, R. L., Anderson, J., Craddock, S.G., & Flynn, P.M. (1997).
Treatment structure and program services in the Drug Abuse Treatment Outcome Study.
Psychology of Addictive Behaviors, 11, 244-260.
Ettner, S.L., Huang, D., Evans, E., Ash, D.R., Hardy, M., Jourabchi, M., & Hser, Y.
(2006). Health Services Research, 41, 192-213.
Fagan, J. (1990). Intoxication and aggression. In M. Tonry and J. Q. Wilson(Eds.),Drugs and crime (pp. 241-320). Chicago: University of Chicago Press.
Fagan, J., Weis, J.G., & Cheng, Y.T. (1990). Delinquency and substance abuse among
inner city students. Journal of Drug Issues, 20: 351-402.
Federal Bureau of Investigation. (2005). Crime in the United States, 2005. United
States Department of Justice: Federal Bureau of Investigation.
Field, G. (1998). Continuity of offender treatment: Institution to the community Paper
presented at the Office of National Drug Control Policy's Conference of Scholars and Policy Makers,
Fletcher, B.W., Tims, F.M., & Brown, B.S. (1997). The Drug Abuse Treatment Outcome
Study (DATOS): Treatment evaluation research in the United States Psychology of Addictive
Gendreau, P. (1996). The principles of effective intervention with offenders. In A T.
Harland (Ed.), Choosing correctional options that work (pp 121-146) Thousand Oaks, CA: Sage
Gerstein, D., & Harwood, H.J. (Eds.). (1990) Treating drug problems: A study of the evolution, effectiveness, and financing of public and private drug treatment systems.
Goldman, F. (1981). Drug abuse, crime and economics: The dismal limits of social
choices. In J.A. Inciardi (Ed.), The drugs-crime connection (pp. 155-182) Beverly Hills, CA:
Goldstein, P. (1985). The drugs/crime nexus: A tripartite conceptual framework.
Journal of Drug Issues, 39, 493-495.
Hamid, A. (1998). Drugs in America. Gaithesburg, MD: Aspen Publishers.
Hardwood, H.J., Collins, J.J., Hubbard, R.L., Marsden, M.E., & Rachal, J.V. (1988).
The costs of crime and benefits of drug abuse treatment: A cost benefit analysis using TOPS
data. In C.G. Leukefeld & F.M. Tims (Eds.), Compulsory treatment of drug abuse: Research and clinical practice (NIDA Research Monograph 86, NIH Publication Number 94-3713)
(pp. 209-235). Washington, DC: Government Printing Office.
Harlow, C. W. (1999). Prior abuse reported by inmates and probationers.
Washington, DC: United States Department of Justice.
Hart Research Associate and Coldwater Corporation. (2004). Faces and voices of
Hoffman, J., & Froemke, S. (2007). Addiction: New knowledge, new treatments, new
Hubbard, R.L., Craddock, S.G., Flynn, P.M., Anderson, J., & Etheridge, R.M. (1997).
Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study
(DATOS). Psychology of Addictive Behaviors, 11, 261-278.
Hubbard, R.L., Marsden, M.E., Rachal, J.V., Hardwood, H.J., Cavanaugh, E.R., &
Ginzburg, H.M. (1989). Drug Abuse treatment: A national study of effectiveness. Chapel
Hill: University of North Carolina Press.
Huizinga, D.H., Menard, S., & Elliott, D.S. (1989). Delinquency and drug use:
Temporal and developmental patterns. Justice Quarterly, 6, 419-456.
Human Rights Watch. (2003). Incarcerated America. New York: Author.
Hyman S.E. & Malenka R.C. (2001). Addiction and the brain: the neurobiology of
compulsion and its persistence. Nature Reviews: Neuroscience, 2, 695–703.
Illinois Department of Corrections. (2005). Unpublished admissions chart June 30,
Illinois Department of Human Services. (2003). Illinois Substance abuse plan. Illinois partnerships in prevention and recovery 2003-2007
Inciardi, J. A (1998) Treatment drug-involved offenders Paper presented at the Office
of National Drug Control Policy's Conference of Scholars and Policy Makers, Washington, DC.
Inciardi, J.A., Martin, S. S., & Butzin, C.A. (2004). Five-year outcomes of therapeutic
community treatment of drug involved offenders after release from prison. Crime and
Inciardi, J.A., Horowitz, R., & Pottieger, A.E. (1993). Street kids, street drugs, street crime: An examination of drug abuse and serious delinquency in Miami. Belmont, CA:
Inciardi, J. A., & McBride, D. C. (1991). Treatment alternatives to street crime History, experiences, and issues. Rockville, MD: National Institute on Drug Abuse.
Inciardi, J. A., McBride, D.C., McCoy, H.V., & Chitwood, D.D. (1995). Recent
research on the crack-cocaine/crime connection. Studies on Crime and Crime Prevention, 6,
Johnson, L.D., O’Malley, P., & Eveland, L. (1978). Drugs and delinquency: A search
for casual connections. In D. B. Kandel (Ed.), Longitudinal research on drug use (pp. 47-63).
Johnson, B.D., Wish, E.D., Schmeidler, J., & Huizinga, D. (1993). Concentration of
delinquent offending: Serious drug involvement and high delinquency rates. In R. Dembo
(Ed.), Drugs and crime (pp.1-25). Lanham, MD: University Press of America
Karberg, J. C., & James, D. J. (2005). Substance dependence, abuse, and treatment of jail inmates, 2002. Washington, DC: United States Department of Justice.
Karch, S. (Ed.). (2007). Drug abuse handbook. Boca Raton, FL: CRC Press.
Knight, K., Simpson, D.D., & Hiller, M.L. (1999). Three-year reincarceration
outcomes in-prison therapeutic community treatment in Texas. Prison Journal, 79, 321- 333.
Lab, J.P. (1992). Crime prevention: Approaches, practices, and evaluations.
Lemmer, T.J., Bensinger, G.J., & Lurigio, A.J. (in press). Revisiting the new/old
problem of gangs in Chicago: A historical analysis of police responses. Police Practice and
Leshner, A. I. Addiction is a brain disease and it matters. (1998). National Institute of
Leukefeld, C.G., & Tims, F M. (1992). Drug abuse treatment in prisons and jails.
Rockville, MD: National Institute on Drug Abuse.
Lillie-Blanton, M. (1998). Studies show treatment is effective, but benefits may be overstated. Washington, DC: General Accounting Office.
Lipton, D.S. (1995). The effectiveness of treatment for drug abusers under criminal justice supervision. Washington, DC: National Institute of Justice.
Lipton, D. S. (1998). Principles of correctional therapeutic treatment programming.
New York: National Development and Research Institutes.
Lurigio, A. J. (2002). Coerced drug treatment for offenders: Does it work? GLATTC
Lurigio, A. J. (2006).The disproportionate incarceration of African Americans for
Patent and Know-How License Agreement with Huaren Pharmaceutical Co., Ltd. JMS Co., Ltd. (hereinafter “JMS”) announced that JMS has entered into a Patent and Know-How License Agreement with Huaren Pharmaceutical Co., Ltd. (hereinafter “Huaren”), Qingdao-based Chinese company, regarding medical devices and pharmaceutical drugs for Peritoneal Dialysis. 1. Background and Objectives
96 Publisher 2 ·2008 Das Letzte Auftritte für Fixnet, Mobile, Solutions und der geniale Bluewin-Auftritt wurden alle Schein und Sein durch einen blau-roten Shiitakepilz ersetzt, der sich im Kreis dreht. Sie kennen sicher meine Abneigung gegenüber sich im Kreis drehenden Logo, welches in den Neunzigern Eitelkeit und Egoismus sind Triebkräfte, gegen die es die Websites sämtlich